Advertisement

Index by Author

April 2000; 49 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abraham, R S

    • Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes April 2000 49:548-554; doi:10.2337/diabetes.49.4.548

  2. Abu-Asab, M

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

  3. Accili, D

    • Genetic modifiers of the insulin resistance phenotype in mice. Diabetes April 2000 49:589-596; doi:10.2337/diabetes.49.4.589

  4. Argentaro, A

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  5. Arslanian, S

    • Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes April 2000 49:626-632; doi:10.2337/diabetes.49.4.626

B

  1. Basu, A

    • Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes April 2000 49:611-617; doi:10.2337/diabetes.49.4.611

  2. Basu, R

    • Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes April 2000 49:611-617; doi:10.2337/diabetes.49.4.611

  3. Becker, D

    • Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes April 2000 49:626-632; doi:10.2337/diabetes.49.4.626

  4. Bergman, R N

    • Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes April 2000 49:580-588; doi:10.2337/diabetes.49.4.580

  5. Björnholm, M

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  6. Bornstein, S R

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

  7. Bouwens, L

    • Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes April 2000 49:571-579; doi:10.2337/diabetes.49.4.571

C

  1. Camp, H S

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  2. Catalano, P M

    • Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes April 2000 49:603-610; doi:10.2337/diabetes.49.4.603

  3. Chakrabarti, S

    • Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes April 2000 49:662-666; doi:10.2337/diabetes.49.4.662

  4. Chapman, H

    • v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats. Diabetes April 2000 49:618-625; doi:10.2337/diabetes.49.4.618

  5. Chen, G

    • Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity. Diabetes April 2000 49:562-570; doi:10.2337/diabetes.49.4.562

  6. Chen, S

    • Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes April 2000 49:662-666; doi:10.2337/diabetes.49.4.662

  7. Christiansen, E

    • Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes April 2000 49:580-588; doi:10.2337/diabetes.49.4.580

  8. Chrousos, G P

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

D

  1. David, C S

    • Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes April 2000 49:548-554; doi:10.2337/diabetes.49.4.548

  2. Deng, D X

    • Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes April 2000 49:662-666; doi:10.2337/diabetes.49.4.662

E

  1. Erbey, J R

    • Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes April 2000 49:626-632; doi:10.2337/diabetes.49.4.626

  2. Evans, T

    • Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes April 2000 49:662-666; doi:10.2337/diabetes.49.4.662

F

  1. Fang, J

    • Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes April 2000 49:667-673; doi:10.2337/diabetes.49.4.667

  2. Ferraro, T

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  3. Fida, S

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  4. Frankowski, C L

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  5. Friedman, J E

    • Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes April 2000 49:603-610; doi:10.2337/diabetes.49.4.603

  6. Fujii, N

    • Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes April 2000 49:527-531; doi:10.2337/diabetes.49.4.527

G

  1. Galuska, D

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  2. Gasa, R

    • Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity. Diabetes April 2000 49:562-570; doi:10.2337/diabetes.49.4.562

  3. Glaser, B

    • Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes April 2000 49:667-673; doi:10.2337/diabetes.49.4.667

  4. Glasow, A

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

  5. Gnudi, L

    • Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes April 2000 49:655-661; doi:10.2337/diabetes.49.4.655

  6. Goodyear, L J

    • Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes April 2000 49:527-531; doi:10.2337/diabetes.49.4.527

  7. Gould, G W

    • v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats. Diabetes April 2000 49:618-625; doi:10.2337/diabetes.49.4.618

  8. Gruden, G

    • Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes April 2000 49:655-661; doi:10.2337/diabetes.49.4.655

H

  1. Habinowski, S A

    • Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes April 2000 49:527-531; doi:10.2337/diabetes.49.4.527

  2. Harley, V R

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  3. Hauner, H

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

  4. Hayashi, T

    • Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes April 2000 49:527-531; doi:10.2337/diabetes.49.4.527

  5. Hayward, A

    • Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes April 2000 49:655-661; doi:10.2337/diabetes.49.4.655

  6. Heimberg, H

    • Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes April 2000 49:571-579; doi:10.2337/diabetes.49.4.571

  7. Heremans, Y

    • Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes April 2000 49:571-579; doi:10.2337/diabetes.49.4.571

  8. Hirshman, M F

    • Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes April 2000 49:527-531; doi:10.2337/diabetes.49.4.527

  9. Hohmeier, H E

    • Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity. Diabetes April 2000 49:562-570; doi:10.2337/diabetes.49.4.562

  10. Holman, G D

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  11. Holst, J J

    • Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes April 2000 49:611-617; doi:10.2337/diabetes.49.4.611

  12. Hong, Y H

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  13. Hsu, B Y

    • Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes April 2000 49:667-673; doi:10.2337/diabetes.49.4.667

K

  1. Kasimiotis, H

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  2. Kido, Y

    • Genetic modifiers of the insulin resistance phenotype in mice. Diabetes April 2000 49:589-596; doi:10.2337/diabetes.49.4.589

  3. Kjems, L L

    • Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes April 2000 49:580-588; doi:10.2337/diabetes.49.4.580

  4. Krook, A

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  5. Kruszynska, Y T

    • Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes April 2000 49:633-639; doi:10.2337/diabetes.49.4.633

  6. Kudva, Y C

    • Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes April 2000 49:548-554; doi:10.2337/diabetes.49.4.548

  7. Kutyna, K

    • Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes April 2000 49:667-673; doi:10.2337/diabetes.49.4.667

L

  1. Lefebvre, V

    • Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes April 2000 49:571-579; doi:10.2337/diabetes.49.4.571

  2. Leff, T

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  3. Li, O

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  4. Lister, C A

    • v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats. Diabetes April 2000 49:618-625; doi:10.2337/diabetes.49.4.618

  5. Lund, S

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

M

  1. Madsbad, S

    • Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes April 2000 49:580-588; doi:10.2337/diabetes.49.4.580

  2. Maestrini, S

    • Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes April 2000 49:655-661; doi:10.2337/diabetes.49.4.655

  3. Maier, V H

    • v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats. Diabetes April 2000 49:618-625; doi:10.2337/diabetes.49.4.618

  4. Melvin, D R

    • v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats. Diabetes April 2000 49:618-625; doi:10.2337/diabetes.49.4.618

  5. Mertin, S

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  6. Ming, J E

    • Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes April 2000 49:667-673; doi:10.2337/diabetes.49.4.667

  7. Murphy, G J

    • v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats. Diabetes April 2000 49:618-625; doi:10.2337/diabetes.49.4.618

  8. Myers, M A

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

N

  1. Newgard, C B

    • Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity. Diabetes April 2000 49:562-570; doi:10.2337/diabetes.49.4.562

O

  1. Olefsky, J M

    • Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes April 2000 49:633-639; doi:10.2337/diabetes.49.4.633

  2. Olsson, J

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  3. Orchard, T J

    • Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes April 2000 49:626-632; doi:10.2337/diabetes.49.4.626

P

  1. Päth, G

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

  2. Pedersen, O

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  3. Philippe, N

    • Genetic modifiers of the insulin resistance phenotype in mice. Diabetes April 2000 49:589-596; doi:10.2337/diabetes.49.4.589

  4. Pipeleers, D

    • Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes April 2000 49:571-579; doi:10.2337/diabetes.49.4.571

  5. Poncz, M

    • Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes April 2000 49:667-673; doi:10.2337/diabetes.49.4.667

R

  1. Renier, G

    • Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes April 2000 49:597-602; doi:10.2337/diabetes.49.4.597

  2. Rincón, J

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  3. Rizza, R A

    • Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes April 2000 49:611-617; doi:10.2337/diabetes.49.4.611

  4. Rowley, M J

    • Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes April 2000 49:555-561; doi:10.2337/diabetes.49.4.555

  5. Ruyter, I

    • Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes April 2000 49:603-610; doi:10.2337/diabetes.49.4.603

  6. Ryder, J W

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

S

  1. Saris, W H

    • Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes April 2000 49:640-646; doi:10.2337/diabetes.49.4.640

  2. Sartippour, M R

    • Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes April 2000 49:597-602; doi:10.2337/diabetes.49.4.597

  3. Schäffer, A A

    • Genetic modifiers of the insulin resistance phenotype in mice. Diabetes April 2000 49:589-596; doi:10.2337/diabetes.49.4.589

  4. Scherbaum, W A

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

  5. Schrauwen, P

    • Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes April 2000 49:640-646; doi:10.2337/diabetes.49.4.640

  6. Shah, P

    • Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes April 2000 49:611-617; doi:10.2337/diabetes.49.4.611

  7. Shao, J

    • Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes April 2000 49:603-610; doi:10.2337/diabetes.49.4.603

  8. Shen, X

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  9. Smith, S

    • Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes April 2000 49:603-610; doi:10.2337/diabetes.49.4.603

  10. Sobel, B E

    • Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes April 2000 49:633-639; doi:10.2337/diabetes.49.4.633

  11. Stanley, C A

    • Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes April 2000 49:667-673; doi:10.2337/diabetes.49.4.667

  12. Strominger, J L

    • Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes April 2000 49:548-554; doi:10.2337/diabetes.49.4.548

T

  1. Thomas, S

    • Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes April 2000 49:655-661; doi:10.2337/diabetes.49.4.655

  2. Tran, V V

    • Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity. Diabetes April 2000 49:562-570; doi:10.2337/diabetes.49.4.562

  3. Tsokos, M

    • Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes April 2000 49:532-538; doi:10.2337/diabetes.49.4.532

V

  1. Vanbogelen, R

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  2. Van De Casteele, M

    • Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes April 2000 49:571-579; doi:10.2337/diabetes.49.4.571

  3. van Marken Lichtenbelt, W D

    • Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes April 2000 49:640-646; doi:10.2337/diabetes.49.4.640

  4. Vella, A

    • Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes April 2000 49:611-617; doi:10.2337/diabetes.49.4.611

  5. Viberti, G C

    • Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes April 2000 49:655-661; doi:10.2337/diabetes.49.4.655

  6. Vølund, A

    • Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes April 2000 49:580-588; doi:10.2337/diabetes.49.4.580

W

  1. Wagenmakers, A J

    • Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes April 2000 49:640-646; doi:10.2337/diabetes.49.4.640

  2. Wallberg-Henriksson, H

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  3. Westerterp, K R

    • Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes April 2000 49:640-646; doi:10.2337/diabetes.49.4.640

  4. Williams, K V

    • Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes April 2000 49:626-632; doi:10.2337/diabetes.49.4.626

  5. Wilson, S B

    • Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes April 2000 49:548-554; doi:10.2337/diabetes.49.4.548

  6. Wise, S C

    • Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes April 2000 49:539-547; doi:10.2337/diabetes.49.4.539

  7. Witters, L A

    • Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes April 2000 49:527-531; doi:10.2337/diabetes.49.4.527

Y

  1. Yamashita, H

    • Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes April 2000 49:603-610; doi:10.2337/diabetes.49.4.603

  2. Yang, J

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  3. Youngren, J

    • Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes April 2000 49:603-610; doi:10.2337/diabetes.49.4.603

  4. Yu, J G

    • Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes April 2000 49:633-639; doi:10.2337/diabetes.49.4.633

Z

  1. Zierath, J R

    • Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes April 2000 49:647-654; doi:10.2337/diabetes.49.4.647

  2. Zonca, S

    • Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes April 2000 49:655-661; doi:10.2337/diabetes.49.4.655

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement